{"resourceType":"Bundle","id":"tests-031889e2-0353-4c2e-82c0-f422e15aacaa-bundle","type":"transaction","entry":[{"fullUrl":"https://madie.cms.gov/Patient/031889e2-0353-4c2e-82c0-f422e15aacaa","resource":{"resourceType":"Patient","id":"031889e2-0353-4c2e-82c0-f422e15aacaa","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-patient"]},"extension":[{"url":"http://hl7.org/fhir/us/core/StructureDefinition/us-core-race","extension":[{"url":"ombCategory","valueCoding":{"system":"urn:oid:2.16.840.1.113883.6.238","code":"1002-5","display":"American Indian or Alaska Native","userSelected":true}},{"url":"text","valueString":"American Indian or Alaska Native"}]},{"url":"http://hl7.org/fhir/us/core/StructureDefinition/us-core-ethnicity","extension":[{"url":"ombCategory","valueCoding":{"system":"urn:oid:2.16.840.1.113883.6.238","code":"2135-2","display":"Hispanic or Latino","userSelected":true}},{"url":"text","valueString":"Hispanic or Latino"}]}],"identifier":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/v2-0203","code":"MR"}]},"system":"https://bonnie-fhir.healthit.gov/","value":"63232f15414ba67d4e1d1c29"}],"name":[{"family":"DENEXPass","given":["ProcedurePalliativeCare"]}],"gender":"male","birthDate":"2006-12-31"},"request":{"method":"PUT","url":"Patient/031889e2-0353-4c2e-82c0-f422e15aacaa"}},{"fullUrl":"https://madie.cms.gov/Encounter/4b143c22-e69c-43ae-a539-a0ab419c4e3f","resource":{"resourceType":"Encounter","id":"4b143c22-e69c-43ae-a539-a0ab419c4e3f","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-encounter"]},"status":"finished","class":{"system":"http://terminology.hl7.org/CodeSystem/v3-ActCode","code":"IMP","display":"inpatient"},"type":[{"coding":[{"system":"http://snomed.info/sct","version":"2022-03","code":"183452005","display":"Emergency hospital admission (procedure)","userSelected":true}]}],"subject":{"reference":"Patient/031889e2-0353-4c2e-82c0-f422e15aacaa"},"period":{"start":"2026-01-01T00:00:00.000+00:00","end":"2026-01-03T00:35:00.000+00:00"}},"request":{"method":"PUT","url":"Encounter/4b143c22-e69c-43ae-a539-a0ab419c4e3f"}},{"fullUrl":"https://madie.cms.gov/MedicationRequest/bfa8666b-1f7e-4c1a-9236-323a66d03dfe","resource":{"resourceType":"MedicationRequest","id":"bfa8666b-1f7e-4c1a-9236-323a66d03dfe","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-medicationrequest"]},"status":"active","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"discharge","display":"Discharge","userSelected":true}]}],"doNotPerform":false,"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1298088","display":"flurazepam hydrochloride 15 MG Oral Capsule","userSelected":true}]},"subject":{"reference":"Patient/031889e2-0353-4c2e-82c0-f422e15aacaa"},"authoredOn":"2026-01-03T00:05:00.000+00:00","requester":{"reference":"Practitioner/f007","display":"Patrick Pump"}},"request":{"method":"PUT","url":"MedicationRequest/bfa8666b-1f7e-4c1a-9236-323a66d03dfe"}},{"fullUrl":"https://madie.cms.gov/MedicationRequest/94b44e65-ebb9-41d3-bab7-ad2bdd92129d","resource":{"resourceType":"MedicationRequest","id":"94b44e65-ebb9-41d3-bab7-ad2bdd92129d","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-medicationrequest"]},"status":"active","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"discharge","display":"Discharge","userSelected":true}]}],"doNotPerform":false,"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1010600","display":"buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film","userSelected":true}]},"subject":{"reference":"Patient/031889e2-0353-4c2e-82c0-f422e15aacaa"},"authoredOn":"2026-01-01T00:05:00.000+00:00","requester":{"reference":"Practitioner/f007","display":"Patrick Pump"}},"request":{"method":"PUT","url":"MedicationRequest/94b44e65-ebb9-41d3-bab7-ad2bdd92129d"}},{"fullUrl":"https://madie.cms.gov/Procedure/c626431b-d171-4c5d-9e82-0a8d024f5854","resource":{"resourceType":"Procedure","id":"c626431b-d171-4c5d-9e82-0a8d024f5854","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-procedure"]},"extension":[{"url":"http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-recorded","valueDateTime":"2026-01-03T00:10:00.000+00:00"}],"status":"completed","code":{"coding":[{"system":"http://snomed.info/sct","version":"2022-03","code":"792902005","display":"Drug addiction therapy using buprenorphine and naloxone (regime/therapy)","userSelected":true}]},"subject":{"reference":"Patient/031889e2-0353-4c2e-82c0-f422e15aacaa"},"performedDateTime":"2026-01-01T00:10:00.000+00:00"},"request":{"method":"PUT","url":"Procedure/c626431b-d171-4c5d-9e82-0a8d024f5854"}},{"fullUrl":"https://madie.cms.gov/Coverage/706b5080-de98-40f5-b5c8-13cf64d5b1d2","resource":{"resourceType":"Coverage","id":"706b5080-de98-40f5-b5c8-13cf64d5b1d2","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-coverage"]},"status":"active","beneficiary":{"reference":"Patient/031889e2-0353-4c2e-82c0-f422e15aacaa"},"payor":[{"reference":"Organization/80e3e0d1-b2aa-43a6-b1d2-00bfa3164a0f"}]},"request":{"method":"PUT","url":"Coverage/706b5080-de98-40f5-b5c8-13cf64d5b1d2"}},{"fullUrl":"https://madie.cms.gov/Organization/553b2752-4ad0-4129-b23f-f0d2222c3f57","resource":{"resourceType":"Organization","id":"80e3e0d1-b2aa-43a6-b1d2-00bfa3164a0f","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-organization"]},"identifier":[{"use":"temp","system":"urn:oid:2.16.840.1.113883.4.4","value":"21-3259825"}],"active":true,"type":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/organization-type","code":"pay","display":"Payer"}]}],"name":"Blue Cross Blue Shield of Texas","telecom":[{"system":"phone","value":"(+1) 972-766-6900"}],"address":[{"use":"billing","type":"postal","line":["P.O. Box 660044"],"city":"Dallas","state":"TX","postalCode":"75266-0044","country":"USA"}]},"request":{"method":"PUT","url":"Organization/80e3e0d1-b2aa-43a6-b1d2-00bfa3164a0f"}},{"fullUrl":"https://madie.cms.gov/MeasureReport/29717875-0c01-4491-b03a-8f76348515d3","resource":{"resourceType":"MeasureReport","id":"29717875-0c01-4491-b03a-8f76348515d3","meta":{"profile":["http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/test-case-cqfm"]},"contained":[{"resourceType":"Parameters","id":"06645c2f-9fb1-4b75-a33c-e7d071519a97-parameters","parameter":[{"name":"subject","valueString":"031889e2-0353-4c2e-82c0-f422e15aacaa"}]}],"extension":[{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-inputParameters","valueReference":{"reference":"#06645c2f-9fb1-4b75-a33c-e7d071519a97-parameters"}},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-testCaseDescription","valueMarkdown":"Enc first day of MP, pt in MAT program for opioids, tx plan includes buprenorhine tx. "}],"modifierExtension":[{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-isTestCase","valueBoolean":true}],"status":"complete","type":"individual","measure":"https://madie.cms.gov/Measure/CMS506FHIRSafeUseofOpioids","period":{"start":"2026-01-01","end":"2026-12-31"},"group":[{"population":[{"code":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-population","code":"initial-population","display":"Initial Population"}]},"count":1},{"code":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-population","code":"denominator","display":"Denominator"}]},"count":1},{"code":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-population","code":"denominator-exclusion","display":"Denominator Exclusion"}]},"count":1},{"code":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-population","code":"numerator","display":"Numerator"}]},"count":0}]}]},"request":{"method":"PUT","url":"MeasureReport/29717875-0c01-4491-b03a-8f76348515d3"}}]}